Michele Bottosso

9PUBLICATIONS
41CO-AUTHORS
Cancer diagnosisCellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 09, 2026
Proactive Brain Screening Using Contrast-Enhanced Brain CT Scans in HER2+ Metastatic Breast Cancer.

Gaia Griguolo, Michele Bottosso, Giusy Landa

|Jun 07, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome.

Michele Bottosso, Benjamin Verret, Olivier Caron

|Apr 24, 2024
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer.

Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci

|Jul 07, 2023
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.

Federica Miglietta, Moira Ragazzi, Bethania Fernandes

|May 20, 2022
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.

Federica Miglietta, Gaia Griguolo, Michele Bottosso

Pageof 2